-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On LB Pharmaceuticals with Buy Rating, Announces Price Target of $45

Benzinga·04/27/2026 11:16:53
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on LB Pharmaceuticals (NASDAQ:LBRX) with a Buy rating and announces Price Target of $45.